These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 12192539)

  • 1. Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
    Maleno I; López-Nevot MA; Cabrera T; Salinero J; Garrido F
    Cancer Immunol Immunother; 2002 Sep; 51(7):389-96. PubMed ID: 12192539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of HLA class I altered phenotypes in colorectal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
    Maleno I; Cabrera CM; Cabrera T; Paco L; López-Nevot MA; Collado A; Ferrón A; Garrido F
    Immunogenetics; 2004 Jul; 56(4):244-53. PubMed ID: 15258706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity at 6p21 underlying [corrected] HLA class I downregulation in Chinese primary esophageal squamous cell carcinomas.
    Yang Y; Zhang J; Miao F; Wei J; Shen C; Shen Y; Xie W
    Tissue Antigens; 2008 Aug; 72(2):105-14. PubMed ID: 18721270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low frequency of HLA haplotype loss associated with loss of heterozygocity in chromosome region 6p21 in clear renal cell carcinomas.
    Maleno I; Lopez Nevot MA; Seliger B; Garrido F
    Int J Cancer; 2004 Apr; 109(4):636-8. PubMed ID: 14991587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular strategies to define HLA haplotype loss in microdissected tumor cells.
    Ramal LM; Maleno I; Cabrera T; Collado A; Ferron A; Lopez-Nevot MA; Garrido F
    Hum Immunol; 2000 Oct; 61(10):1001-12. PubMed ID: 11082513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LOH at 6p21.3 region and HLA class I altered phenotypes in bladder carcinomas.
    Maleno I; Romero JM; Cabrera T; Paco L; Aptsiauri N; Cozar JM; Tallada M; López-Nevot MA; Garrido F
    Immunogenetics; 2006 Jul; 58(7):503-10. PubMed ID: 16705407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC expression on human tumors--its relevance for local tumor growth and metastasis.
    Garrido F; Ruiz-Cabello F
    Semin Cancer Biol; 1991 Feb; 2(1):3-10. PubMed ID: 1912516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15.
    Garrido MA; Rodriguez T; Zinchenko S; Maleno I; Ruiz-Cabello F; Concha Á; Olea N; Garrido F; Aptsiauri N
    Immunogenetics; 2018 Nov; 70(10):647-659. PubMed ID: 30145665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas.
    Feenstra M; Veltkamp M; van Kuik J; Wiertsema S; Slootweg P; van den Tweel J; de Weger R; Tilanus M
    Tissue Antigens; 1999 Sep; 54(3):235-45. PubMed ID: 10519360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity at 6p21 and HLA class I expression in esophageal squamous cell carcinomas in China.
    Zhao X; Sun Q; Tian H; Cong B; Jiang X; Peng C
    Asian Pac J Cancer Prev; 2011; 12(10):2741-5. PubMed ID: 22320985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsatellite instability analysis in tumors with different mechanisms for total loss of HLA expression.
    Jimenez P; Cantón J; Concha A; Cabrera T; Fernández M; Real LM; García A; Serrano A; Garrido F; Ruiz-Cabello F
    Cancer Immunol Immunother; 2000 Mar; 48(12):684-90. PubMed ID: 10752476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered HLA class I expression in non-small cell lung cancer is independent of c-myc activation.
    Redondo M; Ruiz-Cabello F; Concha A; Cabrera T; Pérez-Ayala M; Oliva MR; Garrido F
    Cancer Res; 1991 May; 51(9):2463-8. PubMed ID: 1849792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haplotype loss of HLA class I antigen as an escape mechanism from immune attack in lung cancer.
    So T; Takenoyama M; Mizukami M; Ichiki Y; Sugaya M; Hanagiri T; Sugio K; Yasumoto K
    Cancer Res; 2005 Jul; 65(13):5945-52. PubMed ID: 15994973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of HLA haplotype in lung cancer cell lines: implications for immunosurveillance of altered HLA class I/II phenotypes in lung cancer.
    Hiraki A; Kaneshige T; Kiura K; Ueoka H; Yamane H; Tanaka M; Harada M
    Clin Cancer Res; 1999 Apr; 5(4):933-6. PubMed ID: 10213231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antigen processing machinery of class I human leukocyte antigens: linked patterns of gene expression in neoplastic cells.
    Giorda E; Sibilio L; Martayan A; Moretti S; Venturo I; Mottolese M; Ferrara GB; Cappellacci S; Eibenschutz L; Catricalà C; Grammatico P; Giacomini P
    Cancer Res; 2003 Jul; 63(14):4119-27. PubMed ID: 12874016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of homozygosity of the HLA region in melanoma cell lines reveals a pattern compatible with extensive loss of heterozygosity.
    Rodriguez T; Méndez R; Roberts CH; Ruiz-Cabello F; Dodi IA; López Nevot MA; Paco L; Maleno I; Marsh SG; Pawelec G; Garrido F
    Cancer Immunol Immunother; 2005 Feb; 54(2):141-8. PubMed ID: 15592718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of HLA haplotype and B locus down-regulation in melanoma cell lines.
    Marincola FM; Shamamian P; Alexander RB; Gnarra JR; Turetskaya RL; Nedospasov SA; Simonis TB; Taubenberger JK; Yannelli J; Mixon A
    J Immunol; 1994 Aug; 153(3):1225-37. PubMed ID: 8027550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
    Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
    Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated expression of SerpinA1 and SerpinA3 in HLA-positive cervical carcinoma.
    Kloth JN; Gorter A; Fleuren GJ; Oosting J; Uljee S; ter Haar N; Dreef EJ; Kenter GG; Jordanova ES
    J Pathol; 2008 Jul; 215(3):222-30. PubMed ID: 18438953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity at 6p21.3 underlying HLA class I downregulation in gastric cancer.
    Wang XC; Zhang JQ; Shen YQ; Miao FQ; Xie W
    J Exp Clin Cancer Res; 2006 Mar; 25(1):115-9. PubMed ID: 16761627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.